Lack Of Certain Gene Expression Sets Stage For Breast Cancer

Scientists have identified key steps in breast-tissue cell division that go awry when CHFR's action is low or absent. The gene's expression is missing in more than a third of breast cancers. The findings could make it possible to identify which patients are more likely to benefit from taxanes, a class of widely used cancer drugs which includes paclitaxel and docetaxel.

Read the whole article on Science Daily

More from Science Daily